Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, announced that it, with partner OntoChem GmbH, has identified its first therapeutic candidate against Covid-19, and has advanced the compound into biological testing.
View full press release